Envestnet Asset Management’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Sell |
74,007
-22,593
| -23% | -$734K | ﹤0.01% | 2699 |
|
|
2025
Q1 | $3.65M | Buy |
96,600
+41,517
| +75% | +$1.57M | ﹤0.01% | 2343 |
|
|
2024
Q4 | $4.51M | Buy |
55,083
+6,121
| +13% | +$501K | ﹤0.01% | 2169 |
|
|
2024
Q3 | $5.59M | Buy |
48,962
+1,001
| +2% | +$114K | ﹤0.01% | 2031 |
|
|
2024
Q2 | $3.62M | Buy |
47,961
+5,268
| +12% | +$398K | ﹤0.01% | 2239 |
|
|
2024
Q1 | $2.92M | Sell |
42,693
-6,169
| -13% | -$421K | ﹤0.01% | 2339 |
|
|
2023
Q4 | $3.07M | Buy |
48,862
+9,393
| +24% | +$590K | ﹤0.01% | 2205 |
|
|
2023
Q3 | $2.01M | Buy |
39,469
+17,117
| +77% | +$873K | ﹤0.01% | 2375 |
|
|
2023
Q2 | $1.12M | Buy |
22,352
+12,469
| +126% | +$623K | ﹤0.01% | 2673 |
|
|
2023
Q1 | $370K | Buy |
9,883
+2,684
| +37% | +$101K | ﹤0.01% | 3336 |
|
|
2022
Q4 | $345K | Buy |
+7,199
| New | +$345K | ﹤0.01% | 3335 |
|